Newswise — WHAT:A media briefing about new consensus conference findings that highlight the need for a new approach to better diabetes management. This conference will determine when the risks of diabetes begin.
WHO:"¢ Alan J. Garber, MD, PhD, FACE, Chair of task force and writing committee, The Diagnosis and Management of Pre-Diabetes in the Continuum of Hyperglycemia, Board of Directors, American Association of Clinical Endocrinologists, Professor in the Departments of Medicine, Biochemistry and Molecular Biology, and Molecular and Cellular Biology, Baylor College of Medicine
"¢ Yehuda Handelsman MD, FACP, FACE, Co-chair of programming, The Diagnosis and Management of Pre-Diabetes in the Continuum of Hyperglycemia, Medical Director, Metabolic Institute of America, Chair & Program Director, 6th World Congress on the Insulin Resistance Syndrome " 2008 Chair, International Committee for Insulin Resistance, Treasurer, American Association of Clinical Endocrinologists (AACE), Immediate Past President, California Chapter AACE, Senior Scientific Consultant, Metabolic Endocrine Education Foundation
"¢ Daniel Einhorn, MD, FACP, FACE, Co-chair finance and programming, The Diagnosis and Management of Pre-Diabetes in the Continuum of Hyperglycemia, Vice-President, American Association of Clinical Endocrinologists, Clinical Professor of Medicine, University of California San Diego, Medical Director, Scripps Whittier Institute for Diabetes, Diabetes and Endocrine Associates
WHY:The Centers for Disease Control and Prevention (CDC) shocked the world by announcing that eight percent of the American population suffers from diabetes. In the same report, the CDC also indicated "another 57 million people are estimated to have pre-diabetes," a condition that puts people at increased risk for diabetes. Until now, there has never been a consensus about when patients with pre-diabetes become at risk for the complications of diabetes. These complications include heart attacks, blindness, congestive heart failure, chronic kidney disorder and possibly even death. In 2007, the economic costs of diabetes totaled 174 billion dollars. For these reasons, diabetes experts throughout the world are meeting in Washington, DC, to answer these questions:
"¢ What are the clinical risks of not treating pre-diabetes?"¢ Can society afford the costs of treating of not treating the pre-diabetes state?"¢ What goals and treatment modalities should be the focus of the management of pre-diabetes or how early in the continuum should we treat diabetes?
WHEN AND WHERE:Wednesday, July 23, 200812:00 - 1:00 PM EDT(Lunch will be provided)
National Press Club529 14th Street NW, 13th FloorMurrow RoomWashington, DC 20045
A full list of speakers and participants is available at http://media.aace.com/section_display.cfm?section_id=1.
Hosted by the American College of Endocrinology and the American Association of Clinical Endocrinologists
RSS